Home
Scholarly Works
Clinical Efficacy and Safety Versus Biological...
Conference

Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients

Authors

Federici AB; Iorio A; Castaman G

Volume

116

Pagination

pp. 110-111

Publisher

AMER SOC HEMATOLOGY

Publication Date

November 19, 2010

Name of conference

52nd Annual Meeting of the American-Society-of-Hematology (ASH)

Conference place

Orlando, FL

Conference start date

December 4, 2010

Conference end date

December 7, 2010

Conference proceedings

BLOOD

Issue

21

ISSN

0006-4971

Contact the Experts team